Dr. Sol J. Barer is a Chairman at Teva Pharmaceutical Industries Ltd., a Chairman at Centrexion Therapeutics Corp., a Non-Executive Chairman at Aevi Genomic Medicine, Inc., a Chairman at Edge Therapeutics, Inc., a Lead Independent Director at ContraFect Corp., a Chairman at Medgenics Medical Israel Ltd. and a Managing Director at SJBarer Consulting LLC.
He is on the Board of Directors at ContraFect Corp., Semorex, Inc., Brooklyn College Foundation, Liberty Science Center and Tourette Syndrome Association. Dr. Barer was previously employed as a Non-Executive Chairman by RestorGenex Corp., an Independent Non-Executive Chairman by InspireMD, Inc., an Independent Director by Aegerion Pharmaceuticals, Inc., a Chairman by University of Medicine & Dentistry of New Jersey, an Independent Director by Amicus Therapeutics, Inc., an Executive Chairman by Celgene Corp., a Chairman-Trustees Board by Biotechnology Council of New Jersey, Inc., a Commissioner by New Jersey Commission on Science & Technology, and a Trustee by Rutgers State University of New Jersey.
He also served on the board at BioNJ, Inc., Cerecor, Inc., Nobex Corp. and Pharmaceutical Research & Manufacturers of America.
He received his undergraduate degree from Brooklyn College and a doctorate degree from Rutgers State University of New Jersey.